TABS-Featured
Global Leprosy (Hansen’s disease) Strategy 2021 – 2030
The World Health Organization’s Global Leprosy Strategy 2021 – 2030, “Toward Zero Leprosy,” outlines global targets for 2030 and includes 4 strategic pillars.
GPZL 2020 Impact Report
Our 2020 impact report highlights our work in COVID-19 response, leprosy research, and country partnerships.
COVID-19 & Leprosy Resources
Visit the Zero Leprosy COVID-19 hub for the latest advice, resources, and news related to leprosy during the COVID-19 pandemic.
WHO Technical Guidance: Leprosy/Hansen’s disease contact tracing and post-exposure prophylaxis
“In order to bring down the case detection among leprosy contacts from Point A to Point B, programmes can choose to treat 100 contacts with leprosy and nobody with chemoprophylaxis or provide chemoprophylaxis to all contacts and treat only 43 … More WHO Technical Guidance: Leprosy/Hansen’s disease contact tracing and post-exposure prophylaxis
The COVID-19 Crisis and Persons Affected by Leprosy Fact Sheet
Persons affected by leprosy have been especially impacted by the worst consequences of the COVID-19 pandemic. Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. The Global Partnership for Zero Leprosy COVID-19 Emergency Response Working Group 2 and UN Special Rapporteur Alice Cruz, gathered data from 100+ persons affected and partners, representing 24 countries on available programmes and resources offering support to persons affected during this time. This fact sheet highlights some of the measures taken by governments and NGOs in the represented countries, and underscores the need for increased support.
Updated: 11/06/2020
Advice about leprosy and COVID-19
Advice about leprosy and COVID-19 from the WHO Global Leprosy Programme, ILEP, UN Special Rapporteur Alice Cruz, and GPZL. Includes guidance on diagnosis and clinical management of leprosy patients, public health aspects of leprosy in the COVID-19 pandemic, and services for persons living with disabilities and/or psychosocial consequences of leprosy.